Indication

Parathyroid hyperactivity localization

"Parathyroid hyperactivity localization" refers to the diagnostic and preoperative imaging process used to identify hyperfunctioning parathyroid tissue in patients with hyperparathyroidism, rather than being a distinct medical disease entity. Read more about Parathyroid hyperactivity localization

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Parathyroid hyperactivity localization therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Parathyroid hyperactivity localization preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Parathyroid hyperactivity localization.

"Parathyroid hyperactivity localization" refers to the diagnostic and preoperative imaging process used to identify hyperfunctioning parathyroid tissue in patients with hyperparathyroidism, rather than being a distinct medical disease entity.

This clinical state affects the endocrine system, where autonomous or reactive overactivity within one or more parathyroid glands—predominantly driven by solitary adenomas, multiglandular hyperplasia, or rarely carcinoma—causes pathological hypersecretion of parathyroid hormone.

This hypersecretion disrupts calcium homeostasis, precipitating hypercalcemia, bone demineralization, and nephrolithiasis.

Diagnostic localization aims to pinpoint the precise anatomical or ectopic site of the hyperactive gland tissue to facilitate targeted, minimally invasive surgical excision.

Personalize your experience

Follow Parathyroid hyperactivity localization and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it